comparemela.com
  1. Home
  2. Live Updates
  3. Centenary Chair - Breaking News

Latest Breaking News On - Centenary chair - Page 1 : comparemela.com

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases.

Mustapha haddachAmy conradLuc furicRoss hannanAustralian national universityDepartment of defenseDean research biomedicalCancer researchProstate cancer research programDepartment of cancer biologyPimera therapeutics incPimera therapeuticsTranslational prostate cancer researchPeter maccallum cancer centreProfessor ross hannanCentenary chair

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases.

Mustapha haddachAmy conradLuc furicRoss hannanAustralian national universityDepartment of defenseDean research biomedicalCancer researchProstate cancer research programDepartment of cancer biologyPimera therapeutics incPimera therapeuticsTranslational prostate cancer researchPeter maccallum cancer centreProfessor ross hannanCentenary chair

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.